Frontlight ResearchEarly access
Not yet recruitingNo phase
A Study of Mitral Annular Disjunction in Mitral Valve Prolapse Patients and Arrhythmia Risk
Key facts
- Who runs it
- Assiut University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 30 people, planned
- Started
- 14 Feb 2025
- Expected to end
- 30 Dec 2026
- Type of study
- Observational
- Record updated
- 19 December 2024
Who can take part
- Age
- 18 months and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- All consecutive patients > 18 years of age presenting to Assiut University Heart Hospital with MVP and more than moderate MR
Who cannot take part
- Previous mitral valve surgery; MVP due to infective endocarditis; Moderate or more significant aortic stenosis, aortic regurgitation or mitral stenosis; Congenital heart disease and poor image quality precluding accurate assessment of the mitral valve
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study investigates the characteristics and prevalence of mitral annular disjunction in patients with mitral valve prolapse with severe mitral regurgitation (MR) at Assiut University Heart Hospital.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 19 December 2024